DCM
IPCI

DAFNA Capital Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

DAFNA Capital Management’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-27,926
Closed -$631K – 80
2014
Q4 		$631K Buy
27,926
+20,647
+284% +$558K 0.5% 45
2014
Q3 		$219K Buy
+7,279
New +$210K 0.22% 51

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

DAFNA Capital Management's IPCI Position: Q1 2015 in Review

DAFNA Capital Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2015, closing a stake of 27,926 shares — an estimated $631K sold.

DAFNA Capital Management first reported a position in IPCI in Q3 2014 and held it in 2 quarters. The position peaked at $631K in Q4 2014. 19 funds tracked by Wall St. Rank hold IPCI as of Q1 2015.

  • DAFNA Capital Management reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2015 after selling out during the quarter.
  • DAFNA Capital Management sold 27,926 Intellipharmaceuticals International Inc. shares in Q1 2015, an estimated $631K.
  • DAFNA Capital Management first reported a position in Intellipharmaceuticals International Inc. in Q3 2014 and held it in 2 quarters.
  • DAFNA Capital Management's Intellipharmaceuticals International Inc. position peaked at $631K in Q4 2014.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2015.

Based on DAFNA Capital Management's 13F filing for Q1 2015, filed 15 May 2015.